George Weston (WN) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
22 Nov, 2025Opening remarks and agenda
First-ever joint AGM for George Weston and Loblaw, held in a hybrid format to engage both in-person and virtual shareholders.
Meeting procedures, voting instructions, and Q&A protocols were outlined, with emphasis on shareholder participation.
Recognition of board members, management, auditors, and special guests, including students from Bloor Collegiate.
Financial performance review
George Weston reported consolidated revenues over CAD 61 billion, up 2.5%, and adjusted net earnings per share up 13.2% for 2024.
Strong cash flow of CAD 1.1 billion supported share repurchases and nearly CAD 400 million in dividends; a 9% dividend increase was announced.
Loblaw achieved improved sales momentum, market share growth, and stable gross margins; food same-store sales rose 1.5%, drug retail same-store sales up 2.4%.
Loblaw's adjusted consolidated EBITDA grew 5.7%, with adjusted earnings per share up 10.3% and retail free cash flow at CAD 1.5 billion.
Loblaw repurchased CAD 1.8 billion in shares, invested CAD 2.2 billion in the business, and delivered a 49.2% total shareholder return.
Choice Properties maintained 97.6% occupancy, increased same-asset NOI by 3.2%, and grew funds from operations by 2.9%.
Choice increased its annual unitholder distribution and has delivered an 8.4% annualized total return since IPO.
Board and executive committee updates
All director nominees for both companies were current directors and stood for re-election.
Board and management roles, including secretaries and scrutineers, were confirmed for meeting proceedings.
Latest events from George Weston
- Q4 adjusted diluted EPS up 15.2%, revenue up 11.2%, with strong outlook for 2026.WN
Q4 20254 Mar 2026 - Adjusted EPS rose 9.3% as operational gains offset a major legal settlement charge.WN
Q2 20244 Mar 2026 - Q3 adjusted EPS up 15.1%, revenue up 4.6%, and full-year earnings outlook raised.WN
Q3 202514 Nov 2025 - Adjusted EBITDA and revenue rose, but net earnings fell on fair value adjustments.WN
Q2 202529 Jul 2025 - Adjusted EBITDA rose 6.9% while net earnings plunged on a non-cash Trust Unit loss.WN
Q3 202413 Jun 2025 - Adjusted EPS up 12.2% on strong Loblaw results; dividend raised 9%.WN
Q1 20256 Jun 2025 - Robust 2024 results with higher adjusted earnings, strong cash flow, and positive 2025 outlook.WN
Q4 20245 Jun 2025